BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25741648)

  • 1. Cyclosporine versus tacrolimus: cost-effectiveness analysis for renal transplantation in Brazil.
    Guerra Júnior AA; Silva GD; Andrade EI; Cherchiglia ML; Costa Jde O; Almeida AM; Acurcio Fde A
    Rev Saude Publica; 2015; 49():13. PubMed ID: 25741648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cost effectiveness of tacrolimus versus microemulsified cyclosporin: a 10-year model of renal transplantation outcomes.
    Orme ME; Jurewicz WA; Kumar N; McKechnie TL
    Pharmacoeconomics; 2003; 21(17):1263-76. PubMed ID: 14986738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus versus cyclosporin in renal transplantation in Italy: cost-minimisation and cost-effectiveness analyses.
    Lazzaro C; McKechnie T; McKenna M
    J Nephrol; 2002; 15(5):580-8. PubMed ID: 12455727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cyclosporine versus tacrolimus in kidney transplants in Brazil: a cost comparison].
    Guerra Junior AA; Acúrcio Fde A; Andrade EI; Cherchiglia ML; Cesar CC; Queiroz OV; Silva GD
    Cad Saude Publica; 2010 Jan; 26(1):163-74. PubMed ID: 20209220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus Versus Cyclosporine as Primary Immunosuppressant After Renal Transplantation: A Meta-Analysis and Economics Evaluation.
    Liu JY; You RX; Guo M; Zeng L; Zhou P; Zhu L; Xu G; Li J; Liu D
    Am J Ther; 2016; 23(3):e810-24. PubMed ID: 25299636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaco-economic study of FK 506 (Prograf) and cyclosporine A Neoral in cadaveric renal transplantation.
    Morris-Stiff G; Richards T; Singh J; Baboolal K; Balaji V; Ostrowski K; Moore R; Darby C; Lord R; Jurewicz WA
    Transplant Proc; 1998 Jun; 30(4):1285-6. PubMed ID: 9636521
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost-effectiveness of immunosuppressive regimens in renal transplant recipients in Germany: a model approach.
    Jürgensen JS; Arns W; Hass B
    Eur J Health Econ; 2010 Feb; 11(1):15-25. PubMed ID: 19296139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-year posttransplant graft survival in renal-transplant patients with graft function at 6 months receiving tacrolimus or cyclosporine microemulsion within a triple-drug regimen.
    Irish W; Sherrill B; Brennan DC; Lowell J; Schnitzler M
    Transplantation; 2003 Dec; 76(12):1686-90. PubMed ID: 14688516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The long-term outcomes and costs of diabetes mellitus among renal transplant recipients: tacrolimus versus cyclosporine.
    Woodward RS; Flore MC; Machnicki G; Brennan DC
    Value Health; 2011 Jun; 14(4):443-9. PubMed ID: 21315636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.
    Woodroffe R; Yao GL; Meads C; Bayliss S; Ready A; Raftery J; Taylor RS
    Health Technol Assess; 2005 May; 9(21):1-179, iii-iv. PubMed ID: 15899149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the frequency and costs of posttransplantation hospitalizations in patients receiving tacrolimus versus cyclosporine.
    Neylan JF; Sullivan EM; Steinwald B; Goss TF
    Am J Kidney Dis; 1998 Nov; 32(5):770-7. PubMed ID: 9820446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cost-utility analysis of prolonged-release tacrolimus relative to immediate-release tacrolimus and ciclosporin in liver transplant recipients in the UK.
    Muduma G; Odeyemi I; Pollock RF
    J Med Econ; 2016 Oct; 19(10):995-1002. PubMed ID: 27172118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model.
    Jones-Hughes T; Snowsill T; Haasova M; Coelho H; Crathorne L; Cooper C; Mujica-Mota R; Peters J; Varley-Campbell J; Huxley N; Moore J; Allwood M; Lowe J; Hyde C; Hoyle M; Bond M; Anderson R
    Health Technol Assess; 2016 Aug; 20(62):1-594. PubMed ID: 27578428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive therapy for kidney transplantation in children and adolescents: systematic review and economic evaluation.
    Haasova M; Snowsill T; Jones-Hughes T; Crathorne L; Cooper C; Varley-Campbell J; Mujica-Mota R; Coelho H; Huxley N; Lowe J; Dudley J; Marks S; Hyde C; Bond M; Anderson R
    Health Technol Assess; 2016 Aug; 20(61):1-324. PubMed ID: 27557331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cost-effectiveness analysis of tacrolimus versus cyclosporine microemulsion following kidney transplantation.
    Craig AM; McKechnie T; McKenna M; Klein W; Schindler TM
    Transplant Proc; 2002 Aug; 34(5):1646. PubMed ID: 12176519
    [No Abstract]   [Full Text] [Related]  

  • 16. A randomized, prospective, pharmacoeconomic trial of tacrolimus versus cyclosporine in combination with thymoglobulin in renal transplant recipients.
    Hardinger KL; Bohl DL; Schnitzler MA; Lockwood M; Storch GA; Brennan DC
    Transplantation; 2005 Jul; 80(1):41-6. PubMed ID: 16003231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine versus tacrolimus in immunosuppressive maintenance regimens in renal transplants in Brazil: survival analysis from 2000 to 2004.
    Guerra AA; Cesar CC; Cherchiglia ML; Andrade EI; de Queiroz OV; Silva GD; de Assis Acurcio F
    Ann Pharmacother; 2010 Jan; 44(1):192-201. PubMed ID: 20009005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability and costs of once-daily and twice-daily tacrolimus formulations in de novo kidney transplantation.
    Glander P; Waiser J; Kasbohm S; Friedersdorff F; Peters R; Rudolph B; Wu K; Budde K; Liefeldt L
    Clin Transplant; 2018 Aug; 32(8):e13311. PubMed ID: 29888809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of new immunosuppressive regimens on cost of renal transplant maintenance immunosuppression.
    Gentil MA; González-Roncero F; Cantarell C; López M; Marco J
    Transplant Proc; 2005 Apr; 37(3):1441-2. PubMed ID: 15866631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten-year kidney transplant survival of cyclosporine- or tacrolimus-treated patients in Brazil.
    Gomes RM; Guerra Júnior AA; Lemos LL; Costa Jde O; Almeida AM; Alvares J; Filho CS; Cherchiglia ML; Andrade EI; Godman B; Acurcio FA
    Expert Rev Clin Pharmacol; 2016 Jul; 9(7):991-9. PubMed ID: 27181131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.